Previous analysis has exclusively focused on non-demented Aβ-positive participants in order to examine the effects of sTREM2 and connectivity on the rate of change of tau-PET during the early stages of Alzheimer's disease. The gene discussed is MAPT; the disease is Alzheimer disease.